GIP and GLP-1 receptor agonists are increasingly prescribed for the management of type 2 diabetes and obesity due to their demonstrated efficacy in achieving glycemic control and clinically meaningful weight loss
Rest days are non-negotiable for recovery, especially during weight loss when energy availability is lower
ALLERGENS: Contains no yeast, dairy, egg, gluten, soy or wheat
Gastroparesis Gastroparesis is a long-term medical condition marked by a slowdown in the stomachs ability to empty food into the small intestine without any physical blockage
Serious side effects are rare, but kidney function and hydration status should be monitored
Particularly, dysfunction of EAAC1, which is a neuronal transporter for cysteine and glutamate uptake, impairs neuronal GSH synthesis to cause GSH depletion in aging-related neurodegenerative diseases